相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer
Laura Vidal et al.
CLINICAL CANCER RESEARCH (2008)
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus
Jian Qiao et al.
CLINICAL CANCER RESEARCH (2008)
Reovirus: Viral therapy for cancer 'as nature intended'
C. Comins et al.
CLINICAL ONCOLOGY (2008)
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial
C. L. White et al.
GENE THERAPY (2008)
Gene therapy progress and prospects cancer: oncolytic viruses
T-C Liu et al.
GENE THERAPY (2008)
Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer
Timothy Kottke et al.
MOLECULAR THERAPY (2008)
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
Roberto Cattaneo et al.
NATURE REVIEWS MICROBIOLOGY (2008)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy
Jian Qiao et al.
NATURE MEDICINE (2008)
The therapeutic efficacy of anti-vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice
Qi Li et al.
CLINICAL CANCER RESEARCH (2007)
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow
Caroline J. Breitbach et al.
MOLECULAR THERAPY (2007)
Sunitinib malate and multiple receptor tyrosine kinases inhibitors: Are they also novel drugs for chronic and neurophatic pain?
Luigi Di Lorenzo
JOURNAL OF CLINICAL ONCOLOGY (2007)
Systemic efficacy with oncolytic virus therapeutics: Clinical proof-of-concept and future directions
Ta-Chiang Liu et al.
CANCER RESEARCH (2007)
Molecular basis for sunitinib efficacy and future clinical development
Sandrine Faivre et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Sorafenib for the treatment of advanced renal cell carcinoma
Robert C. Kane et al.
CLINICAL CANCER RESEARCH (2006)
Vascular disrupting agents
M. J. Pilat et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Vascular endothelial growth factor signaling pathways: Therapeutic perspective
Marcin Kowanetz et al.
CLINICAL CANCER RESEARCH (2006)
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
Giulia Fulci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Synergistic antitumor effects of immune cell-viral biotherapy
SH Thorne et al.
SCIENCE (2006)
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
O Casanovas et al.
CANCER CELL (2005)
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Immature B cell malignancies synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR)
A El-Obeid et al.
LEUKEMIA RESEARCH (2004)
Vascular targeting agents as cancer therapeutics
PE Thorpe
CLINICAL CANCER RESEARCH (2004)
Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors
D Jevremovic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
P Gregorevic et al.
NATURE MEDICINE (2004)
Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
HF Dvorak
JOURNAL OF CLINICAL ONCOLOGY (2002)
Cells as vehicles for cancer gene therapy: The missing link between targeted vectors and systemic delivery?
K Harrington et al.
HUMAN GENE THERAPY (2002)
Reovirus oncolysis of human breast cancer
KL Norman et al.
HUMAN GENE THERAPY (2002)
Genetically engineered vesicular stomatitis virus in gene therapy: Application for treatment of malignant disease
M Fernandez et al.
JOURNAL OF VIROLOGY (2002)
Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
D Kirn et al.
NATURE MEDICINE (2001)
Reovirus as an oncolytic agent against experimental human malignant gliomas
ME Wilcox et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
分享论文
